Navigation Links
SNM Symposium on Multimodality Cardiovascular Molecular Imaging
Date:3/18/2009

WHAT: SNM Symposium on Multimodality Cardiovascular Molecular Imaging

This two-day symposium focuses on advances in stem cell therapy, leading-edge research in imaging technology and targeted imaging of the cardiovascular system, including imaging of cardiovascular receptors, vascular biology, myocardial metabolism and myocardial repair.

SNM and the International Partnership for Critical Markers of Disease will host a satellite meeting devoted to FDA requirements for manufacturing PET radiopharmaceuticals the evening of Friday, May 1. This meeting will take place immediately following the conclusion of the Multimodality Cardiovascular Molecular Imaging Symposium.

Registration is free for members of the press and freelancers with a letter of assignment. Advance and on-site phone interviews can also be arranged with presenters for members of the press who wish to cover the symposium remotely.

WHEN: Thursday, April 30Friday, May 1, 2009

WHERE: Natcher Auditorium, National Institutes of Health, Bethesda, Md.

WHY: The symposium brings together individuals from multiple scientific disciplinesincluding medicine, chemistry, engineering, physics, molecular biology, cardiovascular physiology and imaging scienceswith the goal of collaborating, sharing research and promoting an advanced understanding of the emerging field of cardiovascular molecular imaging.

This meeting continues the work of an earlier initiative held at the National Institutes of Health, which served as the basis for the first textbook dedicated to the field of cardiovascular molecular imaging. The 2009 meeting is designed to stimulate further growth in the field by attracting individuals from both the basic science and clinical communities, with a special emphasis on encouraging participation by junior scientists. The overall structure of the meeting includes a series of lectures by experts in the field, panel discussions and an abstra
'/>"/>

Contact: Amy Shaw
ashaw@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Symposium to look at genetic basis of exercise
2. Public Policy Center hosts flood symposium March 10-12
3. AAAS Symposium: Emerging threats to tropical, temperate and ocean ecosystems
4. Symposium at UH will address how to put sustainability into practice
5. Survival in a Changing World: The Journal of Experimental Biology 2009 symposium
6. Childrens National convenes first childhood obesity symposium
7. CTRC-AACR San Antonio Breast Cancer Symposium
8. The Camille & Henry Dreyfus Foundation to host important symposium on chemistry and the environment
9. Counter-terrorism symposium held at NJIT tomorrow
10. AVS 55th International Symposium & Exhibition, Oct. 19-24
11. Penn presents inaugural symposium on applied mathematics and computational science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Social Evolution and Yale University offers compelling support for ... can partially predict the likelihood of being diagnosed with ... in life. The study analyzed medical records of 1.75 ... to 30 years, and adjusted for almost all other ... the Proceedings of the Royal Society, London B ...
(Date:9/17/2014)... Mutations in the human retinoblastoma protein gene are ... University scientists have turned to fruit fly eyes to ... , In a paper featured on the cover of ... Chemistry , Michigan State University researchers provide the first ... those present in the human cancer gene, said Irina ...
(Date:9/17/2014)... 1960s. The typical development phases of trees and stands ... as much as 70 percent. This was the outcome ... Universitt Mnchen based on long-term data from experimental forest ... findings were published recently in Nature Communications . ... topic, with the very survival of large forest ecosystems ...
Breaking Biology News(10 mins):Size at birth affects risk of adolescent mental health disorders 2Size at birth affects risk of adolescent mental health disorders 3Abnormal properties of cancer protein revealed in fly eyes 2Global change: Trees continue to grow at a faster rate 2Global change: Trees continue to grow at a faster rate 3
... Ohio Salmonella cells have hijacked the protein-building ... suggests. Scientists say that these bacteria have modified what ... beta form of an amino acid as opposed to ... Beta versions of amino acids occur in nature ...
... NEW YORK, July 6, 2011 Reportlinker.com announces ... in its catalogue: Biobanking: Technologies ... REPORT HIGHLIGHTS ... * An overview of biobanks by types: Population, ...
... ,   SPO (SPOM.OB), a leading ... that it has entered into an Investment Agreement,with Dutchess Opportunity ... Under the terms of the signed agreement, for a ... and Dutchess the,obligation to purchase common stock at a 6% ...
Cached Biology News:Salmonella stays deadly with a 'beta' version of cell behavior 2Salmonella stays deadly with a 'beta' version of cell behavior 3Biobanking: Technologies and Global Markets 2Biobanking: Technologies and Global Markets 3Biobanking: Technologies and Global Markets 4Biobanking: Technologies and Global Markets 5Biobanking: Technologies and Global Markets 6Biobanking: Technologies and Global Markets 7Biobanking: Technologies and Global Markets 8Biobanking: Technologies and Global Markets 9Biobanking: Technologies and Global Markets 10Biobanking: Technologies and Global Markets 11Biobanking: Technologies and Global Markets 12Biobanking: Technologies and Global Markets 13SPO Secures Equity Line Facility of US$5 Million 2SPO Secures Equity Line Facility of US$5 Million 3SPO Secures Equity Line Facility of US$5 Million 4
(Date:9/17/2014)... - Oncothyreon Inc. (NASDAQ: ONTY ) today ... of its Common Stock and Series A Convertible Preferred ... Series A Convertible Preferred Stock is non-voting and convertible ... will be prohibited if, as a result, the holder ... of the Common Stock then outstanding. As part of ...
(Date:9/17/2014)... 17, 2014 A biodegradable polymer ... such as bacteria, fungi, and algae into smaller ... biomass, inorganic compounds, carbon dioxide, and humus in ... base and improved costs, biodegradable polymers are proving ... alternative to conventional polymers. Primary factors that are ...
(Date:9/17/2014)... Intarcia Therapeutics, Inc. today announced the presentation ... cost and predictability of non-adherence in type 2 diabetes ... the European Association for the Study of Diabetes (EASD). ... Ph.D., of Analysis Group, Inc. presented data from the ... to characterize the prevalence of non-adherence and serial non-adherence, ...
(Date:9/17/2014)... Mass. , Sept. 17, 2014 ... a biotechnology company focused on discovering, developing and ... using RNA-targeted technologies, today announced that it has been ... and Trademark Office on its unique delivery system ... ) to phagocytic cells for the treatment of ...
Breaking Biology Technology:Oncothyreon Announces Proposed Public Offerings 2Growing Demand for Eco-Friendly Products Drives the Global Biodegradable Polymers Market, According to New Report by Global Industry Analysts, Inc. 2Growing Demand for Eco-Friendly Products Drives the Global Biodegradable Polymers Market, According to New Report by Global Industry Analysts, Inc. 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 4Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 5RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 2RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 3RXi Pharmaceuticals Strengthens Intellectual Property Portfolio 4
... Leadership Position in the Asia-Pacific ... ... Sept. 26 PAREXEL International,Corporation (Nasdaq: PRXL ), a ... the acquisition,of Taiwan-based APEX International Clinical Research Co., Ltd. ("APEX").,The ...
... Company Inc. (Nasdaq: NSTK ) will be hosting ... on Thursday, October 4, 2007,from 12:00 p.m. - 3:00 ... Times,Square, on 270 West 43rd Street. The luncheon event ... Chairman, President and,Chief Executive Officer and Gordon Brandt, M.D., ...
... at the Clinton Global,Initiative annual conference, PATH ... eliminate epidemic meningitis in Burkina Faso. ... Meningitis,Vaccine Project, a partnership between the World ... Institute of India Limited has been developed,for ...
Cached Biology Technology:PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd. 2PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd. 3PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd. 4PAREXEL International Completes Acquisition of APEX International Clinical Research Co., Ltd. 5Nastech to Host 2007 Analyst and Institutional Investor Day 2Nastech to Host 2007 Analyst and Institutional Investor Day 3PATH, World Health Organization, and Partners Introduce Meningitis Vaccine in Burkina Faso 2PATH, World Health Organization, and Partners Introduce Meningitis Vaccine in Burkina Faso 3
Goat polyclonal to T7 tag (Agarose) Immunogen: Goats were immunized with MASMTGGQQMG (T7) conjugated to KLH.After multiple immunizations in Freund's adjuvant, serum was collected....
... The features we add to WinList ... the product every day. Features like automatic ... are the result of good suggestions, thoughtful ... of the features you depend on are ...
C/EBPdelta Antibody Shipping Temperature: Cold Storage Temperature: -20C...
Rabbit polyclonal to Orexin Prepro ( Abpromise for all tested applications). entrezGeneID: 3060 SwissProtID: O43612...
Biology Products: